Haemonetics: Re-Rating Complete, Time To Cash In
Source: SeekingAlpha
2026-01-11 09:00:08 ET
In August of last year, I concluded that blood had finally arrived in the streets after a tough time for shares of Haemonetics ( HAE ) . Shares plunged, even as the company maintained the full-year guidance, as the growth picture was not too obvious and some leverage was taken on. ...
Read the full article on Seeking Alpha
For further details see:
Haemonetics: Re-Rating Complete, Time To Cash In
Haemonetics Corporation
NASDAQ: HAE
HAE Trading
0.13% G/L:
$59.65 Last:
182,586 Volume:
$60.29 Open:
HAE Latest News
February 23, 2026 04:15:00 pm
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
February 20, 2026 04:05:00 pm
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
HAE Stock Data
$2,748,315,639
45,616,277
0.08%
124
N/A
Medical Equipment & Supplies
Healthcare
US
Boston
